Market Trends– category –
-
Qcells Perovskite-Silicon Tandem Panels Achieve Landmark Reliability & Safety Certifications, Accelerating Commercialization
Autonocion.com Spain Overview Qcells' perovskite-silicon tandem panels have received crucial certification from TÜV Rheinland, confirming compliance with IEC 61215 reliability and UL 61730 safety standards. This milestone signifies a maj... -
Health Electronics Summit 2026 Hosted by Wibu-Systems: Discussing Cybersecurity and Regulatory Compliance for AI-Powered Medical Devices and Wearables
Wibu-Systems Germany Overview The Health Electronics Summit 2026, hosted by Wibu-Systems, focuses on secure product development, protected communication, trustworthy AI, and robust update processes in digital health. The summit will addr... -
CGM Revolutionizes Type 1 & 2 Diabetes Treatment, Expanding to Wellness Management for Healthy Individuals
Facebook (HCPLive) USA Overview Continuous Glucose Monitoring (CGM) has revolutionized Type 1 diabetes treatment and is now poised to do the same for Type 2 diabetes management. Dr. John Anderson of Frist Clinic highlights CGM as an indi... -
UnitedHealthcare Updates CGM and Insulin Delivery Coverage Policy: Non-Invasive CGMs Excluded Due to Lack of Evidence
UHC Provider Portal (UnitedHealthcare) USA Overview UnitedHealthcare (UHC) has updated its medical policy regarding coverage for continuous glucose monitoring (CGM) and insulin delivery systems for diabetes management. The updated policy... -
Cutting-Edge Sensing Technologies Combat Food Adulteration: Electrochemical DNA Biosensor Identifies Porcine DNA in Processed Meats
Analytical Methods International Overview Modern sensing technologies, particularly electrochemical and optical biosensors, are making significant strides in combating food adulteration. A recent review highlighted a label-free electroch... -
CGM Metrics Outperform HbA1c in Assessing Severe Hypoglycemia and DKA Risk in Type 1 Diabetes: ADA-Published Pooled Analysis Reveals
Diabetes Care (American Diabetes Association) USA Overview A pooled analysis of 10 studies involving 1,550 Type 1 diabetes patients, published in the American Diabetes Association's 'Diabetes Care,' revealed that continuous glucose monit... -
CGM Alone Ineffective for Weight Loss: Mayo Clinic Recommends Integration with Nutrition and Exercise Programs
Mayo Clinic Press USA Overview Continuous Glucose Monitors (CGMs), initially developed for diabetes management, are increasingly adopted by healthy individuals for weight loss. Mayo Clinic experts indicate that CGMs alone have limited ef... -
Forbes Details Cedars-Sinai’s Wearable Data & EHR Integration: AI Leveraged to Alleviate Clinician Burden
Forbes USA Overview Forbes reports Cedars-Sinai Hospital has been integrating wearable biosensor data directly into Electronic Health Records (EHRs) for over a decade. The core challenge is developing clinical workflows where this data i... -
FDA Draft IVD Guide Reshapes 510(k) Planning for Portable POCT and Digitally Connected Diagnostic Devices
China Med Device, LLC USA Overview The U.S. FDA released a draft guidance on August 2, 2026, titled 'In Vitro Diagnostic Devices: Classification and Regulatory Pathways Guidance.' This document clarifies the classification and 510(k) sub... -
Dexcom Achieves 13% Q2 Revenue Growth as FDA Approves OTC Glucose Biosensor Stelo for Pediatric Use
Medical Design and Outsourcing USA Overview Dexcom reported a robust 13% year-over-year revenue growth in Q2 2026, demonstrating the efficacy of its CGM technology in non-insulin-using Type 2 diabetes patients. Concurrently, the U.S. FDA...
